TrialFrontiers in immunology2020

Effect of Optimized Immunosuppression (Including Rituximab) on Anti-Donor Alloresponses in Patients With Chronically Rejecting Renal Allografts.

Kin Yee Shiu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.